The authors of the development were PSU specialists.
Russia has developed a neural network that can recognize substandard medicines. The authors of the development were specialists from Penza State University.
In particular, they trained the AI to conduct a rapid test of liquid medicines and check their authenticity. As the university told "Gazeta.Ru", the technique showed 100% accuracy.
In their development, the scientists conducted a study of tensiometric properties of 10 drugs, including popular ones, such as analgin, baralgin, drotaverine, ketanov, no-shepa, ketorol. In all cases when the neural network examined the counterfeit, it pointed out the counterfeit.
PSU scientists are confident that their development can be put into practical application in enterprises that are engaged in the production of medicines.
Earlier it was reported that Sirius is developing a method of cancer treatment based on reprogramming of macrophages.